1-4 of 4
Judith A. James
Close
Sort by
Journal Articles

Elevated Serum Type I Interferon Activity and Type I Interferon Peripheral Blood Gene Signature In a Subset of Patients with Acquired ADAMTS13-Deficient Thrombotic Thrombocytopenic Purpura.

Contessa E. Edgar, PhD, Deirdra Terrell, PhD, Sara K. Vesely, PhD, MPH, Sean Turner, Igor Dozmorov, MD, PhD, Timothy B. Niewold, MD, Mark Barton Frank, PhD, Melissa Bebak, Wendy Klein, Joan T. Merrill, MD, Kathy L. Moser, PhD, Judith A. James, MD, PhD, James N. George, MD, A. Darise Farris, PhD
Journal: Blood
Blood (2010) 116 (21): 3694.
https://doi.org/10.1182/blood.V116.21.3694.3694
Published: 2010
Journal Articles

Are Patients Who Have Recovered From ADAMTS13-Deficient Thrombotic Thrombocytopenia Purpura (TTP) at Risk for Developing Systemic Lupus Erythematosus (SLE)?

Deirdra R. Terrell, PhD, Zayd Al-Nouri, Judith A. James, MD, PhD, Johanna A. Kremer Hovinga Strebel, MD, Bernhard Lämmle, MD, Sara K. Vesely, PhD, MPH, James N. George, MD
Journal: Blood
Blood (2010) 116 (21): 2519.
https://doi.org/10.1182/blood.V116.21.2519.2519
Published: 2010
Journal Articles

Key developmental transitions in human germinal center B cells are revealed by differential CD45RB expression

Stephen M. Jackson, Natessa Harp, Darshna Patel, Jordan Wulf, Erich D. Spaeth, Uzoamaka K. Dike, Judith A. James, J. Donald Capra
Journal: Blood
Blood (2009) 113 (17): 3999–4007.
https://doi.org/10.1182/blood-2008-03-145979
Published: 2009
Journal Articles

The Frequency of Rheumatic Disease Autoantibodies in Patients with ADAMTS13-Deficient Thrombotic Thrombocytopenia Purpura (TTP).

Karen K. Swisher, MD, Qurana F. Lewis, MPH, Judith A. James, MD, PhD, Johanna A. Kremer Hovinga, MD, Bernhard Lämmle, MD, Deirdra R. Terrell, MPH, Sara K. Vesely, PhD, James N. George, MD
Journal: Blood
Blood (2007) 110 (11): 2090.
https://doi.org/10.1182/blood.V110.11.2090.2090
Published: 2007